Company Annexin Pharmaceuticals AB (publ) Nasdaq Stockholm
Equities
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anna Frostegård
FOU | Founder | 51 | 13-12-31 |
Chief Executive Officer | 63 | 17-12-31 | |
Director of Finance/CFO | 53 | 23-04-10 | |
Susan Suchdev
COO | Chief Operating Officer | 52 | - |
Alain Thibault
PRN | Corporate Officer/Principal | - | 23-01-17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 20-12-31 |
Mårten Österlund
BRD | Director/Board Member | 67 | 20-12-31 |
Chief Executive Officer | 63 | 17-12-31 | |
Director/Board Member | 48 | 16-12-31 | |
Director/Board Member | 65 | 15-12-31 | |
Director/Board Member | 66 | 16-12-31 | |
Director/Board Member | 71 | - | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 21-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 526,807,199 | 256,124,467 ( 48.62 %) | 0 | 48.62 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+19.33% | 125B | |
+13.95% | 109B | |
-3.53% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.62% | 16.64B | |
+0.99% | 13.45B | |
+21.79% | 11.32B |